Squarepoint
PRCT icon

Squarepoint’s Procept Biorobotics PRCT Stock Holding History

Squarepoint’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,100
Closed -$974K – 5230
2024
Q4 		$974K Buy
12,100
+1,500
+14% +$128K ﹤0.01% 3090
2024
Q3 		$849K Buy
10,600
+6,200
+141% +$440K ﹤0.01% 2719
2024
Q2 		$269K Sell
4,400
-28,000
-86% -$1.67M ﹤0.01% 3494
2024
Q1 		$1.6M Buy
+32,400
New +$1.54M ﹤0.01% 2246

Other funds holding PRCT

JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Champlain Investment Partners
Champlain Investment Partners Burlington, Vermont $2.9B AUM 23.58% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Rhenman & Partners Asset Management
Rhenman & Partners Asset Management Stockholm, Sweden $903M AUM 49.67% 1-Year Est. Return
Chicago Capital
Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return

Squarepoint's PRCT Position: Q3 2026 in Review

Squarepoint increased its Procept Biorobotics (PRCT) stake by 54% in Q3 2026, buying an estimated $287K and bringing the position to 40,816 shares worth $744K. The position accounts for ﹤0.01% of the portfolio, ranked #3044.

Squarepoint first reported a position in PRCT in Q3 2021 and has held it in 14 quarters since. The position peaked at $12.9M in Q1 2025. 137 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.

  • Squarepoint held 40,816 shares of Procept Biorobotics worth $744K as of Q3 2026.
  • Squarepoint bought 14,386 Procept Biorobotics shares in Q3 2026, an estimated $287K.
  • Procept Biorobotics made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #3044 holding.
  • Squarepoint first reported a position in Procept Biorobotics in Q3 2021 and has held it in 14 quarters since.
  • Squarepoint's Procept Biorobotics position peaked at $12.9M in Q1 2025.
  • 137 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.